In 2022, there were 158 biopharmaceutical active ingredients for oncology in phase I of the development pipeline in Germany. By contrast, there were only eight for respiratory diseases.
Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group
Characteristic
Phase I
Phase II
Phase III
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Phase I/IIa is included in Phase I; Active ingredients included in the approval process in Phase II; Active ingredients in studies conducted worldwide by companies operating in Germany.
¹ Produced biotechnologically and genetically.
² Including antianemics, antithrimbotics, fibrinolytics etc., excluding hematological oncology.
³ Eye and ear diseases.
⁴ Including active ingredients for muscles, bones, cardiovascular system diseases etc.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
vfa. (July 1, 2023). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group." Chart. July 1, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. (2023). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of Biopharmaceutical Active Ingredients in The Development Pipeline in Germany in 2022, by Disease Group." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa, Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group Statista, https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/ (last visited July 22, 2024)
Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2022, by disease group [Graph], vfa, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/